Skip to main content

People in the News: HiberGene Dx Names New CEO; BioFire Dx Appoints CFO

Premium

Infectious disease diagnostics developer HiberGene Diagnostics has appointed Tony Hill as CEO.

Hill joins HiberGene from Innogenetics, where he was global sales director. Prior to this, he was vice president at OraSure Technologies, and he has also held a number of positions at Sigma Aldrich.

HiberGene has developed a molecular diagnostic test for Meningococcus and plans to develop a test for pneumococcal meningitis, the two most common forms of meningitis. Using a novel rapid amplification platform, HiberGene has produced a rapid and highly sensitive diagnostic test that can be used in almost any clinical or laboratory setting, the company said. HiberGene is currently fundraising to help commercialize the assays and fund further ongoing research and development on a range of infectious diseases.


BioFire Diagnostics has appointed Robert Lollini as CFO.

Lollini most recently served as CEO, and formerly as CFO of Myrexis, a Utah-based biotechnology company. He remains a member of its board of directors. From 1993 to 2007, Lollini held multiple executive positions at drug-delivery company Iomed, which was acquired in May 2007. Earlier in his career, he held various executive management positions at RP Scherer.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.